SUMF2 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of SUMF2 monoclonal antibodies for research focused on understanding SUMF2 protein function. SUMF2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SUMF2, or Sulfatase Modifying Factor 2, plays a vital role in the post-translational modification of sulfatases, which are enzymes involved in the degradation of sulfated glycosaminoglycans. The proper functioning of SUMF2 is essential for maintaining cellular homeostasis and regulating various biological processes, including cell signaling and extracellular matrix remodeling. Research has shown that SUMF2 dysfunction can contribute to several pathological conditions. Understanding SUMF2's molecular mechanisms and cellular functions continues to be an active area of investigation. Exploring SUMF2's role in both normal physiology and disease states provides opportunities for therapeutic development. Current research focuses on identifying novel functions and regulatory pathways associated with SUMF2. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific knowledge about SUMF2's impact on human health and disease progression.